Histopathological/immunohistochemical factors influencing the uptake of technetium-99m-MIBI in patients with suspected breast cancer.

被引：0
|
作者：
Tiling, R
Linke, R
Stephan, K
Hantschmann, P
Dresel, S
Hahn, K
机构：
[1] Univ Munich, Dept Nucl Med, D-80539 Munich, Germany
[2] Univ Munich, Dept Gynecol & Obstet, D-80539 Munich, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1384
引用
收藏
页码：389P / 389P
页数：1
相关论文
共 50 条
  • [21] ENHANCEMENT BY TETRAPHENYLBORATE OF TECHNETIUM-99M-MIBI UPTAKE KINETICS AND ACCUMULATION IN CULTURED CHICK MYOCARDIAL-CELLS
    PIWNICAWORMS, D
    KRONAUGE, JF
    CHIU, ML
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (10) : 1992 - 1999
  • [22] Correlation between uptake of 99mTc-MIBI and prognostic factors of breast cancer.
    Qing, ZH
    Tong, LX
    Qing, CZ
    Ming, ZG
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 292P - 293P
  • [23] Size or histology? Factors affecting uptake of Tc-99m sestaMIBI in breast lesions in patients with suspected primary breast cancer.
    Cwikla, JB
    Barlow, RV
    Buscombe, JR
    Kelleher, SM
    Hinton, J
    Parbhoo, SP
    Thakrar, DS
    Deery, A
    Crow, J
    Hilson, AJW
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 991 - 991
  • [24] Preoperative localization of parathyroid lesions in hyperparathyroidism: Relationship between Technetium-99m-MIBI uptake and oxyphil cell content
    Carpentier, A
    Jeannotte, S
    Verreault, J
    Lefebvre, B
    Bisson, G
    Mongeau, CJ
    Maheux, P
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08) : 1441 - 1444
  • [25] Technetium-99m-tetrofosmin scintimammography in patients with suspicion of breast cancer.
    Schillaci, O
    Scopinaro, F
    Danieli, R
    Tavolaro, R
    Picardi, V
    Cannas, P
    Broglia, L
    Colella, AC
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1143 - 1143
  • [26] Tc-99m MIBI in suspected recurrent breast cancer
    Cwikla, JB
    Kolasinska, AD
    Buscombe, JR
    Hilson, AJW
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2000, 15 (04) : 367 - 372
  • [27] Immunohistologic assessment of Tc-99m-(V)DMSA and Tc-99m-MIBI uptake in breast cancer.
    Papantoniou, V
    Stipsaneli, A
    Arka, A
    Louvrou, A
    Lazaris, D
    Nakopoulou, L
    Palikarona, P
    Keramopoulos, A
    Michalas, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 977 - 977
  • [28] Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer
    VillanuevaMeyer, J
    Leonard, MH
    Briscoe, E
    Cesani, F
    Ali, SA
    Rhoden, S
    Hove, M
    Cowan, D
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (06) : 926 - 930
  • [29] Scintimammography with technetium-99m tetrofosmin in suspected breast cancer
    Schillaci, O
    Scopinaro, F
    Danieli, R
    Picardi, V
    Tavolaro, R
    Cannas, P
    Colella, AC
    ANTICANCER RESEARCH, 1997, 17 (3B) : 1623 - 1626
  • [30] 99mTc-MIBI scintimammography as a complement of the mammography in patients with suspected breast cancer.: A multicentre experience
    Prats, E
    Banzo, J
    Merono, E
    Herranz, R
    Carril, JM
    BREAST, 2001, 10 (02): : 109 - 116
12345